Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghainyou Medical CoSHSE:688085 -2.66%83 EV-to-FCF is 114.68 as of Jul. 19, 2026, which is 91% above its 10-year median of 59.93. GuruFocus rates SHSE:688085 with a GF Score™ of 83/100 and a GF Value™ of ¥16.00 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 414 Medical Devices & Instruments companies, Shanghainyou Medical Co ranks worse than 88.41% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Shanghainyou Medical Co's Enterprise Value is ¥4,361.6 Mil.
Shanghainyou Medical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ¥38.0 Mil. Therefore, Shanghainyou Medical Co's EV-to-FCF for today is 114.68.
The historical rank and industry rank for Shanghainyou Medical Co's EV-to-FCF or its related term are showing as below:
SHSE:688085'
s EV-to-FCF Range Over the Past 10 Years
Min: -2153.27 Med: 59.93 Max: 392.44
Current: 114.68
During the past 10 years, the highest EV-to-FCF of Shanghainyou Medical Co was 392.44. The lowest was -2153.27. And the median was 59.93.
SHSE:688085's EV-to-FCF is ranked worse than 88.41% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.16
vs SHSE:688085: 114.68
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghainyou Medical Co (SHSE:688085) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghainyou Medical Co's PE Ratio (TTM) for today is calculated as:
Shanghainyou Medical Co's share price for today is ¥13.18.
Shanghainyou Medical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.155.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688085 vs ABT, SYK, MDT: EV-to-FCF Comparison
For the Medical Devices subindustry, Shanghainyou Medical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghainyou Medical Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghainyou Medical Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Shanghainyou Medical Co's EV-to-FCF falls into.
Shanghainyou Medical Co's current Enterprise Value is ¥4,361.6 Mil.
Shanghainyou Medical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥38.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghainyou Medical Co (SHSE:688085) has a EV-to-FCF of 114.68 as of Jul. 19, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghainyou Medical Co and its competitors. This is 91% above median its historical median of 59.93. According to the industry distribution chart, Shanghainyou Medical Co ranks #366 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 88.4%.
Is Shanghainyou Medical Co's EV-to-FCF too high?
Shanghainyou Medical Co's current EV-to-FCF of 114.68 is 91% above median its 10-year median of 59.93. The Medical Devices & Instruments industry median EV-to-FCF is 23.16. Shanghainyou Medical Co's value of 114.68 is 395.2% above this industry median. Based on the distribution chart, Shanghainyou Medical Co ranks #366 out of 414 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Shanghainyou Medical Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghainyou Medical Co's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghainyou Medical Co ranks #366 out of 414 companies for EV-to-FCF. This places Shanghainyou Medical Co in the lower half of its industry. The industry median EV-to-FCF is 23.16. Shanghainyou Medical Co's value of 114.68 is 395.2% above this benchmark. While the company's 10-year median is 59.93 vs. the industry median of 23.16, Shanghainyou Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.16, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghainyou Medical Co's current EV-to-FCF of 114.68 is 395.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghainyou Medical Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghainyou Medical Co's current EV-to-FCF is 114.68, which is 91% above median its own 10-year median of 59.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghainyou Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghainyou Medical Co (SHSE:688085) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥16.00, compared to a current price of ¥13.18 — trading 17.6% below its estimated fair value. The current EV-to-FCF is 114.68, which is 91% above median its 10-year median of 59.93 and 395.2% above the Medical Devices & Instruments industry median of 23.16. Shanghainyou Medical Co's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Shanghainyou Medical Co (SHSE:688085), the current EV-to-FCF is 114.68 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghainyou Medical Co (SHSE:688085) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghainyou Medical Co stock appears to be undervalued.
The current stock price of ¥13.18 is trading 17.6% below its estimated GF Value™ of ¥16.00.
GuruFocus considers Shanghainyou Medical Co to be Modestly Undervalued.
Key valuation signals for SHSE:688085:
EV-to-FCF: 114.68 (91% above median its 10-year median of 59.93)
GF Value™: ¥16.00 vs. price of ¥13.18 (17.6% below fair value)
Industry Position: 395.2% above the Medical Devices & Instruments median (#366 of 414)
No single metric tells the full story. See the SHSE:688085 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Sanyou Medical Co Ltd is engaged in manufacturing and sales of independently orthopedics implant. The company manufactures medical devices such as type III implantation equipment (orthopedics), type III intracranial hematoma puncture removal equipment, type II dressing, nursing materials, type II surgical instruments and I surgical instruments.
83GF Score
Get the complete analysis for SHSE:688085
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688085 has been successfully added to your 
